BIOLOGICS AND JAK INHIBITORS DECREASE MAJOR CARDIOVASCULAR EVENTS (MACE) IN IBD PATIENTS. DATA FROM A LARGE NATIONAL COHORT. IS IT THE MECHANISM OF THE DRUG OR CONTROL OF DISEASE?

被引：0
|
作者：
Patel, Paraj
Iqbal, Omair
Mohananey, Divyanshu
Bajwa, Saffia
Khani, Masoud
Luo, Jake
Stein, Daniel J.
Hashash, Jana G.
Mansoor, Emad
Cross, Raymond K.
Sinh, Preetika
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
718
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 6 条
  • [1] ANTI TNF MEDICATIONS BUT NOT JAK INHIBITORS ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM. DATA FROM A LARGE NATIONAL COHORT. IS IT THE MECHANISM OF THE DRUG OR THE DISEASE?
    Iqbal, Omair
    Patel, Paraj
    Mohananey, Divyanshu
    Bajwa, Saffia
    Khani, Masoud
    Luo, Jake
    Stein, Daniel J.
    Hashash, Jana G.
    Mansoor, Emad
    Cross, Raymond K.
    Sinh, Preetika
    GASTROENTEROLOGY, 2024, 166 (05) : S1120 - S1120
  • [2] Major Adverse Cardiovascular Events in Patients With IBD Taking Anti-TNF vs JAK Inhibitors: A Propensity Matched Cohort Analysis
    Alsakarneh, Saqr
    Madi, Mahmoud
    Jaber, Fouad
    Farraye, Francis A.
    Faye, Adam S.
    Caldera, Freddy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S733 - S733
  • [3] Discoid Lupus Onset and Decrease Risk of Renal Disease in Patients with Systemic Lupus Erythematosus: Data from a Large Latin American Cohort.
    Pons-Estel, Guillermo J.
    Bao, Gaobin
    Pons-Estel, Bernado
    Wojdyla, Daniel
    Saurit, Veronica
    Alvarellos, Alejandro J.
    Caeiro, Francisco
    Sato, Emilia I.
    Soriano, Enrique R.
    Costallat, Lilian Tereza
    Neira, Oscar
    Iglesias-Gamarra, Antonio A.
    Reyes Llerena, Gil
    Cardiel, Mario
    Acevedo-Vasquez, Eduardo M.
    Chacon, Rosa
    Drenkard, Cristina M.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S427 - S427
  • [4] INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE "JAK-POT" STUDY)
    Aymon, R.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    Cordtz, R. L.
    Diederik, D. C.
    Dreyer, L.
    Elkayam, O.
    Huschek, D.
    Hyrich, K.
    Iannone, F.
    Inanc, N.
    Kearsley-Fleet, L.
    Kvien, T. K.
    Leeb, B.
    Lukina, G.
    Nordstrom, D.
    Onen, F.
    Pavelka, K.
    Pombo-Suarez, M.
    Provan, S. Aarrestad
    Rodrigues, A. M.
    Rotar, Z.
    Strangfeld, A.
    Verschueren, P.
    Zavada, J.
    Courvoisier, D.
    Finckh, A.
    Lauper, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 143 - 145
  • [5] Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)
    Aymon, R.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    Cordtz, R. L.
    De Cock, D.
    Dreyer, L.
    Elkayam, O.
    Huschek, D.
    Hyrich, K. L.
    Iannone, F.
    Inanc, N.
    Kearsley-Fleet, L.
    Kvien, T. K.
    Leeb, B. F.
    Lukina, G.
    Nordstrom, D.
    Onen, F.
    Pavelka, K.
    Pombo-Suarez, M.
    Provan, S.
    Rodrigues, A. M.
    Rotar, Z.
    Strangfeld, A.
    Verschueren, P.
    Zavada, J.
    Courvoisier, D.
    Finckh, A.
    Lauper, K.
    SWISS MEDICAL WEEKLY, 2023, 153 : 2S - 2S
  • [6] Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: A retrospective, observational study based on healthcare claims and national death index data
    Kloner, Robert A.
    Stanek, Eric
    Crowe, Christopher L.
    Singhal, Mukul
    Pepe, Rebecca S.
    Bradsher, Julia
    Rosen, Raymond C.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20 (01): : 38 - 48
1